Correlation Between Protara Therapeutics and GeoVax Labs

Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and GeoVax Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and GeoVax Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protara Therapeutics and GeoVax Labs, you can compare the effects of market volatilities on Protara Therapeutics and GeoVax Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of GeoVax Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and GeoVax Labs.

Diversification Opportunities for Protara Therapeutics and GeoVax Labs

-0.09

Correlation Coefficient

Protara Therapeutics  GeoVax Labs

Good diversification

The 3 months correlation between Protara and GeoVax is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and GeoVax Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeoVax Labs and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with GeoVax Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeoVax Labs has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and GeoVax Labs go up and down completely randomly.

Pair Corralation between Protara Therapeutics and GeoVax Labs

Given the investment horizon of 90 days Protara Therapeutics is expected to generate 0.4 times more return on investment than GeoVax Labs. However, Protara Therapeutics is 2.52 times less risky than GeoVax Labs. It trades about 0.28 of its potential returns per unit of risk. GeoVax Labs is currently generating about 0.07 per unit of risk. If you would invest  183.00  in Protara Therapeutics on August 31, 2024 and sell it today you would earn a total of  121.00  from holding Protara Therapeutics or generate 66.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Protara Therapeutics  vs.  GeoVax Labs

Protara Therapeutics

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Protara Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Protara Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

GeoVax Labs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeoVax Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Protara Therapeutics and GeoVax Labs

The main advantage of trading using opposite Protara Therapeutics and GeoVax Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, GeoVax Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeoVax Labs will offset losses from the drop in GeoVax Labs' long position.

The idea behind Protara Therapeutics and GeoVax Labs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.